---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-386561"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2026-09-09T20:50:50+00:00"
generated_at: "2026-09-09T20:52:06.770138+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Candel Therapeutics files investor presentation; no new material facts disclosed

## Summary
- Candel Therapeutics furnished a corporate investor presentation dated September 2026 under Regulation FD.
- Visible exhibit content is limited to the cover slide; no financial or clinical data is included in the filing text.
- Presentation tagline: 'Tipping the balance in favor of the immune system to fight cancer.'
- No earnings, guidance, or pipeline updates are disclosed in this 8-K.

## SEC filing metadata
- accession: 0001193125-26-386561
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2026-09-09T20:50:50+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/0001193125-26-386561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/d738484d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-386561
- JSON: https://secwatch.observer/filing/0001193125-26-386561.json
- Plain text: https://secwatch.observer/filing/0001193125-26-386561.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.